文献速递前列腺增生与排尿功能障碍

一种新型植入式胫后神经刺激器治疗膀胱过度活动症:单中心新疗法的3个月结果

A New Implanted Posterior Tibial Nerve Stimulator for the Treatment of Overactive Bladder Syndrome: 3-Month Results of a Novel Therapy at a Single Center.
PubMed 文献 · J Urol · 2017-02-09

本研究在15例膀胱过度活动症患者中植入无电池胫后神经刺激装置,评估3个月时的安全性和疗效。结果显示24小时排尿次数、严重尿急发作、严重尿失禁发作及每日漏尿量均显著改善,生活质量提高;1例因疑似感染取出装置。作者认为该新型刺激器安全、易植入且临床效果良好。

要点

  • 15例患者植入无电池胫后神经刺激装置,中位手术时间34分钟。
  • 3个月时24小时排尿次数从11.8±3.5降至8.1±2.0次(p=0.002)。
  • 1例因疼痛和肿胀疑似感染取出装置,组织培养未发现细菌感染。

核心结论

  • 这种新型胫后神经刺激器安全、易于植入且临床效果良好。

研究设计与样本

  • 单中心研究,植入无电池胫后神经刺激装置(BlueWind Medical,Herzliya,以色列)于15例患者。
  • 在激活后3个月通过3天排尿日记、24小时尿垫试验和2份生活质量问卷进行安全性和疗效评估。

主要发现

  • 共纳入2例男性和13例女性,平均年龄54岁(范围19至72岁)。
  • 15例中5例既往接受过经皮胫神经刺激,12例有急迫性尿失禁。
  • 3个月随访时24小时排尿次数从均值±SD 11.8±3.5次/天降至8.1±2.0次/天(p=0.002)。
  • 严重尿急发作次数从6.5±5.1次/天降至2.0±2.1次/天(p=0.002),严重尿失禁发作次数从2.8±5.2次/天降至0.3±0.4次/天(p=0.017)。
  • 每日漏尿量从243±388克降至39±55克(p=0.038),生活质量改善。

关键数值与推荐

  • 中位手术时间34分钟。
  • 植入后3例接受延长抗生素治疗,3例接受止痛药物治疗1周。
  • 1例因疼痛和肿胀疑似感染而取出装置,尽管组织培养未显示细菌感染。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: This study was designed to investigate the safety and performance of a new implantable system for tibial nerve stimulation for overactive bladder symptoms. MATERIALS AND METHODS: A battery-free stimulation device for tibial nerve stimulation (BlueWind Medical, Herzliya, Israel) was implanted in 15 patients. Safety and efficacy assessments were done at 3 months after activation with a 3-day bladder diary, a 24-hour pad test and 2 quality of life questionnaires. RESULTS: Two males and 13 females were enrolled in the study. Mean age was 54 years (range 19 to 72). Five of 15 patients were previously treated with percutaneous tibial nerve stimulation and 12 experienced urgency urinary incontinence. Median operative time was 34 minutes. At 3 months of followup a significant change was seen in 24-hour frequency from a mean ± SD of 11.8 ± 3.5 to 8.1 ± 2.0 times per day (p = 0.002), the number of severe urinary urgency episodes from 6.5 ± 5.1 to 2.0 ± 2.1 times per day (p = 0.002), the number of severe incontinence episodes from 2.8 ± 5.2 to 0.3 ± 0.4 episodes per day (p = 0.017), urinary loss per day from 243 ± 388 to 39 ± 55 gm (p = 0.038) and improvement in quality of life. After implantation, 3 patients received prolonged antibiotic treatment and 3 received pain medication for 1 week. In 1 patient the device was explanted due to pain and swelling suspicious for infection, although tissue cultures did not reveal a bacterial infection. CONCLUSIONS: This novel posterior tibial nerve stimulator is safe and easy to implant with good clinical results.

来源:J Urol,查看原文。版权归原作者所有。

引用

  1. van Breda HMK, Martens FMJ, Tromp J, et al. A New Implanted Posterior Tibial Nerve Stimulator for the Treatment of Overactive Bladder Syndrome: 3-Month Results of a Novel Therapy at a Single Center. J Urol. 2017. PMID: 28189576. doi:10.1016/j.juro.2017.01.078

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。